These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 29498300)

  • 1. Arsenic induces cardiac rhythm dysfunction and acylcarnitines metabolism perturbation in rats.
    Phan NN; Li KL; Lin YC
    Toxicol Mech Methods; 2018 Jul; 28(6):423-431. PubMed ID: 29498300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Literature review and pilot studies of the effect of QT correction formulas on reported beta2-agonist-induced QTc prolongation.
    Milic M; Bao X; Rizos D; Liu F; Ziegler MG
    Clin Ther; 2006 Apr; 28(4):582-90. PubMed ID: 16750469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic arsenic exposure and cardiac repolarization abnormalities with QT interval prolongation in a population-based study.
    Mumford JL; Wu K; Xia Y; Kwok R; Yang Z; Foster J; Sanders WE
    Environ Health Perspect; 2007 May; 115(5):690-4. PubMed ID: 17520054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnitude of error introduced by application of heart rate correction formulas to the canine QT interval.
    King A; Bailie M; Olivier NB
    Ann Noninvasive Electrocardiol; 2006 Oct; 11(4):289-98. PubMed ID: 17040276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bazett and Fridericia QT correction formulas interfere with measurement of drug-induced changes in QT interval.
    Indik JH; Pearson EC; Fried K; Woosley RL
    Heart Rhythm; 2006 Sep; 3(9):1003-7. PubMed ID: 16945790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart rate correction models to detect QT interval prolongation in novel pharmaceutical development.
    Markert M; Shen R; Trautmann T; Guth B
    J Pharmacol Toxicol Methods; 2011; 64(1):25-41. PubMed ID: 21635956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sample size, power calculations, and their implications for the cost of thorough studies of drug induced QT interval prolongation.
    Malik M; Hnatkova K; Batchvarov V; Gang Y; Smetana P; Camm AJ
    Pacing Clin Electrophysiol; 2004 Dec; 27(12):1659-69. PubMed ID: 15613131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of effect of perampanel on QT interval duration: Results from a thorough QT analysis and pooled partial seizure Phase III clinical trials.
    Yang H; Laurenza A; Williams B; Patten A; Hussein Z; Ferry J
    Epilepsy Res; 2015 Aug; 114():122-30. PubMed ID: 26088895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased risk of QT prolongation associated with atherosclerotic diseases in arseniasis-endemic area in southwestern coast of Taiwan.
    Wang CH; Chen CL; Hsiao CK; Chiang FT; Hsu LI; Chiou HY; Hsueh YM; Wu MM; Chen CJ
    Toxicol Appl Pharmacol; 2009 Sep; 239(3):320-4. PubMed ID: 19573547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Halothane-anaesthetized, closed-chest, guinea-pig model for assessment of drug-induced QT-interval prolongation.
    Sakaguchi Y; Takahara A; Nakamura Y; Akie Y; Sugiyama A
    Basic Clin Pharmacol Toxicol; 2009 Jan; 104(1):43-8. PubMed ID: 18699795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olaparib does not cause clinically relevant QT/QTc interval prolongation in patients with advanced solid tumours: results from two phase I studies.
    Swaisland H; Plummer R; So K; Garnett S; Bannister W; Fabre MA; Dota C; Fielding A
    Cancer Chemother Pharmacol; 2016 Oct; 78(4):775-84. PubMed ID: 27553432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of low-moderate urine arsenic and QT interval: Cross-sectional and longitudinal evidence from the Strong Heart Study.
    Moon KA; Zhang Y; Guallar E; Francesconi KA; Goessler W; Umans JG; Best LG; Howard BV; Devereux RB; Okin PM; Navas-Acien A
    Environ Pollut; 2018 Sep; 240():894-902. PubMed ID: 29793197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction of QT values to allow for increases in heart rate in conscious Beagle dogs in toxicology assessment.
    Tattersall ML; Dymond M; Hammond T; Valentin JP
    J Pharmacol Toxicol Methods; 2006; 53(1):11-9. PubMed ID: 15886026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic-pharmacodynamic modeling in the data analysis and interpretation of drug-induced QT/QTc prolongation.
    Piotrovsky V
    AAPS J; 2005 Oct; 7(3):E609-24. PubMed ID: 16353940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing Prolongation of the Heart Rate Corrected QT Interval in Users of Tricyclic Antidepressants: Advice to Use Fridericia Rather Than Bazett's Correction.
    Noordam R; van den Berg ME; Niemeijer MN; Aarts N; Leening MJ; Deckers JW; Hofman A; Rijnbeek PR; Eijgelsheim M; Kors JA; Stricker BH; Visser LE
    J Clin Psychopharmacol; 2015 Jun; 35(3):260-5. PubMed ID: 25856783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bias and variance evaluation of QT interval correction methods.
    Wang Y; Pan G; Balch A
    J Biopharm Stat; 2008; 18(3):427-50. PubMed ID: 18470754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New in vitro model for proarrhythmia safety screening: IKs inhibition potentiates the QTc prolonging effect of IKr inhibitors in isolated guinea pig hearts.
    Kui P; Orosz S; Takács H; Sarusi A; Csík N; Rárosi F; Csekő C; Varró A; Papp JG; Forster T; Farkas AS; Farkas A
    J Pharmacol Toxicol Methods; 2016; 80():26-34. PubMed ID: 27063345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synchronization in the Heart Rate and the Vasomotion in Rat Aorta: Effect of Arsenic Trioxide.
    Cifuentes F; Palacios J; Nwokocha CR
    Cardiovasc Toxicol; 2016 Jan; 16(1):79-88. PubMed ID: 25666560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of peripherally administered urotensin II and arginine vasotocin on the QT interval of the electrocardiogram in trout.
    Vanegas G; Lancien F; Leprince J; Vaudry H; Le Mével JC
    Comp Biochem Physiol C Toxicol Pharmacol; 2016; 183-184():53-60. PubMed ID: 26902806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased incidence of QT interval prolongation in a population receiving lower doses of methadone maintenance therapy.
    Roy AK; McCarthy C; Kiernan G; McGorrian C; Keenan E; Mahon NG; Sweeney B
    Addiction; 2012 Jun; 107(6):1132-9. PubMed ID: 22168435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.